Lv3
400 积分 2026-03-27 加入
Platelet Hyperaggregability is Highly Prevalent in Patients With Chronic Kidney Disease: An Underestimated Risk Indicator of Thromboembolic Events
44分钟前
待确认
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
17天前
已完结
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial
18天前
已完结
Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing
18天前
已完结
Platelet inhibition with tirofiban early during percutaneous coronary intervention: Dosing revisited
18天前
已完结
Tirofiban. A review of its use in acute coronary syndromes
18天前
已完结
Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men
19天前
已完结
FINEARTS-HF — The Latest Masterpiece for MRAs in Heart Failure
22天前
已完结
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study
22天前
已完结
皖公网安备34019202002308
